These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8895555)

  • 1. Induction of apoptosis in androgen-independent mouse mammary cell line by 1, 25-dihydroxyvitamin D3.
    Furuya Y; Ohta S; Shimazaki J
    Int J Cancer; 1996 Sep; 68(1):143-8. PubMed ID: 8895555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis in an androgen-independent mouse cell line by transforming growth factor-beta 1.
    Furuya Y; Ohta S; Shimazaki J
    J Exp Ther Oncol; 1996 Nov; 1(6):377-84. PubMed ID: 9414428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of programmed death/apoptosis androgen-dependent mouse mammary tumor cell line (Shionogi Carcinoma 115) by androgen withdrawal.
    Furuya Y; Isaacs JT; Shimazaki J
    Jpn J Cancer Res; 1995 Dec; 86(12):1159-65. PubMed ID: 8636004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis in androgen-independent mouse mammary tumor cells induced by 5-fluorodeoxyuridine but not by androgen withdrawal.
    Furuya Y; Shimazaki J
    Anticancer Res; 1996; 16(5A):2613-8. PubMed ID: 8917359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis of androgen-independent mammary and prostate cell lines induced by topoisomerase inhibitors: common pathway of gene regulation.
    Furuya Y; Ohta S; Ito H
    Anticancer Res; 1997; 17(3C):2089-93. PubMed ID: 9216669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
    Zhao XY; Ly LH; Peehl DM; Feldman D
    Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant.
    Narvaez CJ; Welsh J
    Endocrinology; 1997 Nov; 138(11):4690-8. PubMed ID: 9348195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.
    Zhao XY; Peehl DM; Navone NM; Feldman D
    Endocrinology; 2000 Jul; 141(7):2548-56. PubMed ID: 10875257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha,25-dihydroxyvitamin D3 induced growth inhibition of PC-3 prostate cancer cells requires an active transforming growth factor beta signaling pathway.
    Murthy S; Weigel NL
    Prostate; 2004 May; 59(3):282-91. PubMed ID: 15042604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a vitamin D3-resistant MCF-7 cell line.
    Narvaez CJ; Vanweelden K; Byrne I; Welsh J
    Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
    Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
    Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
    Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
    J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089.
    VanWeelden K; Flanagan L; Binderup L; Tenniswood M; Welsh J
    Endocrinology; 1998 Apr; 139(4):2102-10. PubMed ID: 9528999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells.
    Eisman JA; Sutherland RL; McMenemy ML; Fragonas JC; Musgrove EA; Pang GY
    J Cell Physiol; 1989 Mar; 138(3):611-6. PubMed ID: 2925799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
    Ikezoe T; Gery S; Yin D; O'Kelly J; Binderup L; Lemp N; Taguchi H; Koeffler HP
    Cancer Res; 2005 Jun; 65(11):4762-8. PubMed ID: 15930295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.
    Myrthue A; Rademacher BL; Pittsenbarger J; Kutyba-Brooks B; Gantner M; Qian DZ; Beer TM
    Clin Cancer Res; 2008 Jun; 14(11):3562-70. PubMed ID: 18519790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,25-Dihydroxyvitamin D₃ and cisplatin synergistically induce apoptosis and cell cycle arrest in gastric cancer cells.
    Bao A; Li Y; Tong Y; Zheng H; Wu W; Wei C
    Int J Mol Med; 2014 May; 33(5):1177-84. PubMed ID: 24573222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth.
    Gavrilov V; Steiner M; Shany S
    Anticancer Res; 2005; 25(5):3425-9. PubMed ID: 16101159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of anchorage-independent growth of JB6 mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3.
    Hosoi J; Abe E; Suda T; Colburn NH; Kuroki T
    Cancer Res; 1986 Nov; 46(11):5582-6. PubMed ID: 3019530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.